Early albuminuria reduction with finerenone (Kerendia) drove protection against chronic kidney disease (CKD) progression in people with type 2 diabetes, according to a post-hoc mediation analysis. At ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback